Influenza Global Market 2018: Key Players – Alere Inc., MedImmune, LLC, Cepheid Inc., GlaxoSmithKline plc and Qiagen N.V.Alere Inc.
Description
Wiseguyreports.Com Adds “Influenza -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database
This BCC Research report is designed to be a helpful business tool that provides a thorough evaluation of the market for influenza vaccines, therapeutics and diagnostics. The geographic scope of this study is global, with emphasis on U.S. and European data. The report identifies markets in general segments: Vaccines, Therapeutics and Diagnostics. Each market segment discussion provides detailed information based on product categories, uses of products, forecasts and competitive analyses. Additionally, the study covers some of the most significant issues, trends and market factors.
Report Includes:
- 25 data tables and 77 additional tables
- An overview of the global influenza market
- Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Identification of segments with high growth potential and their future applications
- Explanation of major drivers and regional dynamics of the market and current trends within the industry
- Detailed profiles of major vendors in the market, including Alere Inc., MedImmune, LLC, Cepheid Inc., GlaxoSmithKline plc and Qiagen N.V.Alere Inc.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/2820035-the-global-influenza-market
BECTON DICKINSON AND COMPANY
CEPHEID
CSL LIMITED
DAIICHI SANKYO
DANAHER CORP.
GLAXOSMITHKLINE PLC
HOLOGIC INC
LUMINEX CORP.
MEDIMMUNE INC.
MedImmune/AstraZeneca
MITSUBISHI TANABE PHARMA CORP.
MYLAN N.V.
ORASURE TECHNOLOGIES
QIAGEN N.V.
QUIDEL CORP.
ROCHE
SANOFI
SANOFI/SANOFI PASTEUR
SEKISUI DIAGNOSTICS LLC
SEQIRUS
Table of Contents
Chapter 1 Introduction
Influenza Overview
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
The Influenza Market: Summary of Major Markets
Leave a Query @ https://www.wiseguyreports.com/enquiry/2820035-the-global-influenza-market
Chapter 3 Industry Overview and Background
Overview
History of the Market
Epidemics and Pandemics in History
Virus Mutations
Influenza Types
WHO and CDC Influenza Response
World Health Organization
Centers for Disease Control and Prevention
U.S. Viral Surveillance
FDA's Vaccine and Related Biological Products Advisory Committee and Vaccine Composition
Vaccine Recommendations
Vaccine Effectiveness
Universal Vaccine
Population Demographics and Influenza Incidence/Mortality
Global Demographics
Global Life Expectancy
Influenza Incidence and Mortality
The 2017-2018 Influenza Season (Through January 2018)
Chapter 4 Global Influenza Vaccine Market
Overview
Current Vaccines
The Global Influenza Vaccine Market
Seasonal versus Pandemic Sales
Regional Market Summary
The U.S. Influenza Vaccine Market
History of Vaccine Manufacturer Participation in the United States
The European Influenza Vaccine Market
Global Competitor Analysis
Influenza Vaccine Developments
Clinical Trials
Chapter 5 Global Influenza Therapeutics Market
Chapter 6 Global Influenza Diagnostic Market
Chapter 7 Influenza Pandemic Impact
Chapter 8 Patent Review/ New Developments
Chapter 9 Analysis of Market Opportunities
Chapter 10 Company Profiles
Significant Company Acquisitions
ALERE INC.
MedImmune/AstraZeneca
MEDIMMUNE INC.
BECTON DICKINSON AND COMPANY
CEPHEID
DAIICHI SANKYO
GLAXOSMITHKLINE PLC
HOLOGIC INC
LUMINEX CORP.
MITSUBISHI TANABE PHARMA CORP.
MYLAN N.V.
ORASURE TECHNOLOGIES
QIAGEN N.V.
QUIDEL CORP.
ROCHE
SANOFI/SANOFI PASTEUR
SEKISUI DIAGNOSTICS LLC
SEQIRUS
Chapter 11 Appendix
Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2820035
Continued...
Contact Us: [email protected] Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
Posted by
Vivian Dsena
on Friday June 22 2018, 9:45 AM EDT.
All trademarks acknowledged.
Filed under Uncategorized.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
